RIT’s Moumita Das elected as American Physical Society fellow

Fellowship program recognizes those with exceptional contributions to physics

2024-01-19

(Press-News.org) Rochester Institute of Technology Professor Moumita Das, from the School of Physics and Astronomy, has been elected an American Physical Society Fellow for her exceptional contributions to physics.

The APS Fellowship Program was created to recognize members who have made advances in physics through original research and publication, innovative contributions in the application of physics to science and technology, or teaching or service in the activities of the organization. No more than one half of 1 percent of the APS membership, excluding students, is recognized with fellowship. Only four people from Das’s field worldwide were elected this year for the award, all via peer nomination.

“I was really happy to be appreciated and recognized by my peers,” said Das. “To me, this honor resonates more deeply than any other accolades, as it’s an affirmation from those who are familiar with my work.”

Das was nominated by APS Division of Soft Matter for fundamental mechanistic insights into the collective properties and rigidity transitions in multi-component biological and bio-inspired soft materials, and for contributions to building an inclusive and diverse soft matter community.

Her work as a theoretical soft matter and biological physicist focuses on the interplay of statistical physics, mechanics, structure, and organization in cells and tissues.

Das has mentored many students across all levels of education, including many fellow women and minorities who have gone on to work in prestigious academic institutions or non-academic research positions. Her undergraduate mentee Ashley Lasko received the 2022-2023 RIT Norman A. Miles Award for Excellence in Academic Study while Das received the Norman A. Miles Award for Academic Excellence in Teaching as her mentor the same year. Lasko is now a Ph.D. student at the University of California, San Francisco. Das’s graduate mentee Lauren Melcher defended her Ph.D. thesis in September 2023 and is now a senior scientist at Pfizer.

“In addition to my research, I’m really proud of my research mentees,” added Das. “They have gone on to be very, very successful.”

RIT now boasts four APS Fellows. Along with Das, Manuela Campanelli was recognized in 2009, Carlos Lousto in 2012, and Scott Franklin in 2012.

The APS’s mission is to advance and diffuse the knowledge of physics for the benefit of humanity, promote physics, and serve the broader physics community. The Society was founded in 1899 and started the Fellowship Program in 1921.

END

ELSE PRESS RELEASES FROM THIS DATE:

New research center to explore how ‘untapped Kingdom’ of fungi can change our world

2024-01-19

A new research centre focused on harnessing the positive powers of fungi is being established at Cranfield University with a £7.2 million injection of funding from Research England. Fungi are one of the most diverse kingdoms in all living organisms and have an estimated global monetary value of 54.57 trillion US dollars. Long used for food and medicine, only a small proportion of classified fungi species has been studied in detail and developed for industrial use – leaving an estimated three million species yet to be discovered and evaluated. To date, research of fungi has largely focused on mitigating negative effects like disease, toxins and food loss. The ...

University of Houston joins SMART Hub, a $5 million Department of Defense consortium

2024-01-19

To tackle the challenges of a shrinking wireless spectrum, the University of Houston has joined the Spectrum Management with Adaptive and Reconfigurable Technology (SMART) Hub – a Department of Defense Spectrum Innovation Center to conduct multifaceted spectrum research to meet national defense needs. The center, led by Baylor University, is a collection of researchers, engineers and economic and policy experts looking to enact a paradigm shift in the use and management of the wireless spectrum. SMART Hub will develop next-generation technologies for unprecedented spectrum agility, to revolutionize ...

Occupational sitting time, leisure physical activity, and all-cause and cardiovascular disease mortality

2024-01-19

About The Study: In this study involving 481,000 individuals over a mean follow-up period of nearly 13 years, individuals who predominantly engaged in sitting at work exhibited a higher risk of mortality from all causes and cardiovascular disease compared with those who predominantly did not sit. Individuals who predominantly sit at work would need to engage in an additional 15 to 30 minutes of physical activity per day to mitigate this increased risk and reach the same level of risk as individuals who predominantly do not sit at work. Authors: Chi-Pang Wen, M.D., Ph.D., of the National Health Research ...

Timing of maternal COVID-19 vaccine and antibody concentrations in infants born preterm

2024-01-19

About The Study: In this prospective cohort study of 220 pregnant individuals with preterm and full-term deliveries, receipt of three or more compared with two doses of COVID-19 vaccine before delivery resulted in 10-fold higher cord anti-Spike antibody levels. Maternal antibody concentration appeared more important than delivery gestational age in determining cord anti-Spike antibody levels. The number of doses and timing considerations for COVID-19 vaccine in pregnancy should include individuals at risk for preterm delivery. Authors: Alisa Kachikis, M.D., M.S., of the University ...

When are opioid prescription limits effective in reducing prescription length?

2024-01-19

Study analyzed a West Virginia policy that tailored duration limits to a patient’s clinical setting Researchers found a 27-57% reduction in prescription length with the tailored policy Additional research is needed on potential consequences of limits, such as use of illicit opioids for pain relief CHICAGO --- Many states have passed new laws that place restrictions on the duration of first-time opioid prescriptions to help address the opioid epidemic. While most laws are one-size-fits-all, policies more tailored to the patient, such as their age or clinical setting (outpatient clinic, emergency room, etc.), were more effective ...

Bacterial meningitis damages one in three children for life

2024-01-19

One in three children who suffer from bacterial meningitis live with permanent neurological disabilities due to the infection. This is according to a new epidemiological study led by Karolinska Institutet and published in leading medical journal JAMA Network Open. For the first time, researchers have identified the long-term health burden of bacterial meningitis. The bacterial infection can currently be cured with antibiotics, but it often leads to permanent neurological impairment. And since children are often affected, ...

McMaster researchers create instruction manual to detect rare cells that could unlock secrets to allergies

2024-01-19

Researchers with McMaster University have created the instruction manual that will help scientists across the globe find hard to detect B cells. Led by PhD student Alyssa Phelps and Department of Medicine Assistant Professor Josh Koenig, researchers wanted to chart a path to finding these cells as part of their work in understanding food allergies. Their work was published in the journal Nature Protocols on Jan. 19, 2024. B cells are a type of immune cell that makes antibodies. These cells help fight conditions like cancer and infections but can also cause autoimmune diseases and allergies. "One of the big problems with trying to study these B ...

Rice’s Amanda Marciel wins NSF CAREER Award

2024-01-19

HOUSTON – (Jan. 19, 2024) – Amanda Marciel describes her current research, supported by a CAREER Award from the National Science Foundation, as an effort to understand and make “really soft, stretchable stuff.” Expressed more formally, she works at the molecular level to design branch elastomers that return to their original shape after being stretched. “What I’m doing is creating synthetic networks that have a gel-like softness and are highly elastic for such applications as stretchable ...

JMC｜Insilico Medicine nominates novel AI-driven PHD inhibitor targeting anemia

2024-01-19

Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine (“InSilico”), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal focusing on critical studies about molecular structure and biological activity, has published the company’s discovery of a novel PHD inhibitor for the treatment of anemia. The academic breakthrough is powered by Chemistry42, its proprietary generative chemistry platform consisting of more than 40 selected generative models. As suggested in previous studies, the inhibition ...

JMC | Insilico Medicine presents the discovery of the potent and selective MYT1 inhibitors for the treatment of cancer through generative AI

2024-01-19

Insilico Medicine(“Insilico”), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research that it has identified MYT1 as a promising new therapeutic target for breast and gynecological cancer, and discovered a series of novel, potent, and highly selective inhibitors specifically targeting MYT1. These findings were supported by Insilico’s AI-driven generative biology and chemistry engine and published in the Journal of Medicinal Chemistry in Dec 2023. Across ...

LAST 30 PRESS RELEASES:

Unexpected human behaviour revealed in prisoner's dilemma study: Choosing cooperation even after defection

Distant relatedness in biobanks harnessed to identify undiagnosed genetic disease

UCLA at ASTRO: Predicting response to chemoradiotherapy in rectal cancer, 2-year outcomes of MRI-guided radiotherapy for prostate cancer, impact of symptom self-reporting during chemoradiation and mor